REVIEW
|
doi:10.20944/preprints202105.0202.v1
Subject:
Medicine And Pharmacology,
Pathology And Pathobiology
Keywords:
metabolic bone disease; burosumab; KRN23; x-linked hypophosphatemia; crysvita; xlh
Online: 10 May 2021 (14:37:10 CEST)
REVIEW
|
doi:10.20944/preprints202307.1470.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
COVID-19; phospho-calcium; parathyroid hormone, post-COVID complications, hypocalcemia, hypophosphatemia.
Online: 21 July 2023 (09:23:41 CEST)
REVIEW
|
doi:10.20944/preprints202403.1532.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
RGS14; FGF23; PTH/PTHrP receptor; NHERF1; NaPi-2a; kidney stones; Tumor Induced Osteomalacia; hyperphosphatemia; hypophosphatemia; allosteric
Online: 26 March 2024 (06:50:38 CET)
REVIEW
|
doi:10.20944/preprints202205.0249.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
X-linked hypophosphatemia; fibroblast growth factor 23; osteomalacia; enthesopathy; secondary hyperparathyroidism; tertiary hyperparathyroidism; chronic kidney disease; oral disease; quality of life; burosumab
Online: 19 May 2022 (04:03:47 CEST)